Article summary
This double-blind, placebo-controlled crossover study (n=20) found that psilocybin reduced acute alpha/beta EEG power and increased gamma-band signal diversity. Lower slow-frequency power at 24 hours was associated with positive life changes reported four weeks later, but these correlations in healthy volunteers do not establish therapeutic efficacy.
Continue to the original publication for the complete article.